The Quiet Revolution in Health Care and Health Product Regulation
This article was originally published in RPM Report
Executive Summary
Compliance is taking on a new meaning for Big Pharma, one that de-emphasizes traditional government oversight in favor of novel, consumer-focused quality measures. The Medicare Part D program is helping to drive the change.